Food insecurity screening and local food access: Contributions to nutritional outcomes among children and adults with cystic fibrosis in the United States

Julianna Bailey(University of Alabama at Birmingham), Gabriela R. Oates(University of Alabama at Birmingham), Kate E. Powers(Albany Medical Center Hospital), Georgia Brown(Cystic Fibrosis Foundation), Keith J. Robinson(University of Vermont), Cristen Clemm(Cystic Fibrosis Foundation), Monir Hossain(University of Alabama at Birmingham), Elliott C. Dasenbrook(Cleveland Clinic), Kim Reno(Cystic Fibrosis Foundation), Dixie Durham(St. Luke's Cystic Fibrosis Center of Idaho), Elizabeth Baker(St. Jude Children's Research Hospital), Michael S. Schechter(Emory University)
Journal of Cystic Fibrosis
September 4, 2023
10.1016/j.jcf.2023.08.006
Cited by 14

Related Papers

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation
|Thorax|2011|501
Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease
|JAMA|2008|377
Association Between Respiratory Tract Methicillin-Resistant S&lt;emph type="ital"&gt;taphylococcus aureus&lt;/emph&gt; and Survival in Cystic Fibrosis
|JAMA|2010|359
Persistent Methicillin-resistant <i>Staphylococcus aureus</i> and Rate of FEV1 Decline in Cystic Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2008|322
Antibiotic Management of Lung Infections in Cystic Fibrosis. I. The Microbiome, Methicillin-Resistant <i>Staphylococcus aureus</i> , Gram-Negative Bacteria, and Multiple Infections
|Annals of the American Thoracic Society|2014|198